APA (7th ed.) Citation

Adam, R., Tibau, A., Molto Valiente, C., Šeruga, B., Ocaña, A., Amir, E., & Templeton, A. J. (2022). Clinical benefit of cancer drugs approved in Switzerland 2010–2019. PLoS ONE, 17(6), 1. https://doi.org/10.1371/journal.pone.0268545

Chicago Style (17th ed.) Citation

Adam, Roman, Ariadna Tibau, Consolación Molto Valiente, Boštjan Šeruga, Alberto Ocaña, Eitan Amir, and Arnoud J. Templeton. "Clinical Benefit of Cancer Drugs Approved in Switzerland 2010–2019." PLoS ONE 17, no. 6 (2022): 1. https://doi.org/10.1371/journal.pone.0268545.

MLA (9th ed.) Citation

Adam, Roman, et al. "Clinical Benefit of Cancer Drugs Approved in Switzerland 2010–2019." PLoS ONE, vol. 17, no. 6, 2022, p. 1, https://doi.org/10.1371/journal.pone.0268545.